Final results of KEYNOTE-355 - report from SABCS2021

from Medical Digest & Congress Report · host Medical Congress News

Professor Javier Cortes speaks about the final results of KEYNOTE-355 trial, a Randomized, double-blind, phase 3 study of pembrolizumab + chemotherapy vs placebo + chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer. Video: https://congressreport.eu/scientific-contents/interview:final-results-keynote-355

Episode metadata supplied by the publisher feed · Published Dec 16, 2021

Embed this episode

Attribution link and audio player

NOW PLAYING

Final results of KEYNOTE-355 - report from SABCS2021

0:00 5:19

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Medical Digest & Congress Report?

This episode is 5 minutes long.

When was this Medical Digest & Congress Report episode published?

This episode was published on December 16, 2021.

Can I download this Medical Digest & Congress Report episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!